Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexhia: Soluble Dexamethasone in Refractory Sciatica
NCT05000658Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in Sciatica, sponsored by CHU de Nantes. Started Dec 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
Sciatica
Beyond the preview
Go deeper on NCT05000658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05000658.